Chen Yu, Wang Xin, Zhang Chunlei, Liu Zhiyong, Li Chao, Ren Zhigang
Gene Hospital of Henan Province, Precision Medicine Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China.
Front Microbiol. 2022 May 6;13:877776. doi: 10.3389/fmicb.2022.877776. eCollection 2022.
Gut microbiota is key to human health and disease. Convincing studies have demonstrated that dysbiosis in the commensal gut microbiota is associated with intestinal and extra-intestinal diseases. Recent explorations have significantly contributed to the understanding of the relationship between gut microbiota and bone diseases (osteoporosis, osteoarthritis, rheumatoid arthritis, and bone cancer). Gut microbiota and its metabolites may become associated with the development and progression of bone disorders owing to their critical role in nutrient absorption, immunomodulation, and the gut-brain-bone axis (regulation hormones). In this work, we review the recent developments addressing the effect of gut microbiota modulation on skeletal diseases and explore a feasible preventive approach and therapy for bone diseases.
肠道微生物群对人类健康和疾病至关重要。有说服力的研究表明,共生肠道微生物群的失调与肠道和肠道外疾病有关。最近的探索对理解肠道微生物群与骨疾病(骨质疏松症、骨关节炎、类风湿性关节炎和骨癌)之间的关系做出了重大贡献。由于肠道微生物群及其代谢产物在营养吸收、免疫调节和肠-脑-骨轴(调节激素)中起关键作用,它们可能与骨疾病的发生和发展相关。在这项工作中,我们综述了肠道微生物群调节对骨骼疾病影响的最新进展,并探索了一种可行的骨疾病预防方法和治疗方法。